Beta cell function after weight loss: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention

European Journal of Endocrinology

Volumn 164, Issue 2, 2011, Pages 231-238

  Hofso D ^a   Jenssen, T ^b,c   Bollerslev, J ^c,d   Ueland, T ^c,e   Godang, K ^c   Stumvoll, M ^f   Sandbu, R ^a   Roislienand J ^a,g   Hjelmesaeth J ^a  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PROINSULIN;

ARTICLE; BODY MASS; CALORIC INTAKE; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STOMACH BYPASS; SURGICAL TECHNIQUE; WEIGHT CHANGE; WEIGHT REDUCTION; ADULT; BYPASS SURGERY; HUMAN CELL; INTERMETHOD COMPARISON; MORBID OBESITY; PANCREAS ISLET CELL FUNCTION; PREDICTION;

ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET, REDUCING; EXERCISE THERAPY; FEMALE; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 78751559992     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0804     Document Type: Article

References (26)

1. Hofsø D, Jenssen T, Hager H, Røislien J & Hjelmesæth J. Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obesity Surgery 2010 20 302-307. (doi:10.1007/s11695-009-0022-5)
2. Stumvoll M, Goldstein BJ & van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005 365 1333-1346. (doi:10.1016/S0140-6736(05)61032-X) (Pubitemid 40501297)
3. Golay A, Felber JP, Dusmet M, Gomez F, Curchod B & Jequier E. Effect of weight loss on glucose disposal in obese and obese diabetic patients. International Journal of Obesity 1985 9 181-191.
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM,Walker EA, Nathan DM & Diabetes Prevention Program Research Group . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002 346 393-403. (doi:10.1056/NEJMoa012512)
5. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H & Swedish Obese Subjects Study Scientific Group . Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New England Journal of Medicine 2004 351 2683-2693. (doi:10.1056/NEJMoa035622)
6. Utzschneider KM, Carr DB, Barsness SM, Kahn SE & Schwartz RS. Diet-induced weight loss is associated with an improvement in beta-cell function in older men. Journal of Clinical Endocrinology and Metabolism 2004 89 2704-2710. (doi:10.1210/jc.2003-031827)
7. Villareal DT, Banks MR, Patterson BW, Polonsky KS & Klein S. Weight loss therapy improves pancreatic endocrine function in obese older adults. Obesity 2008 16 1349-1354. (doi:10.1038/oby.2008.226) (Pubitemid 351770521)
8. Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H & Diabetes Prevention Program Research Group . Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 2005 54 2404-2414. (doi:10.2337/diabetes.54.8.2404)
9. Carr DB, Utzschneider KM, Boyko EJ, Asberry PJ, Hull RL, Kodama K, Callahan HS, Matthys CC, Leonetti DL, Schwartz RS, Kahn SE & Fujimoto WY. A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function. Diabetes 2005 54 340-347. (doi:10.2337/diabetes.54. 2.340)
10. Morinigo R, Lacy AM, Casamitjana R, Delgado S, Gomis R & Vidal J. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obesity Surgery 2006 16 1594-1601. (doi:10.1381/ 096089206779319338)
11. Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M & Mingrone G. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 2009 32 375-380. (doi:10.2337/dc08-1314)
12. Guldstrand M, Ahren B & Adamson U. Improved beta-cell function after standardized weight reduction in severely obese subjects. American Journal of Physiology. Endocrinology and Metabolism 2003 284 E557-E565. (doi:10.1152/ajpendo.00325.2002)
13. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ & Patti ME. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. Journal of Clinical Endocrinology and Metabolism 2007 92 4678-4685. (doi:10.1210/jc.2007-0918) (Pubitemid 350223444)
14. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo- Clavell ML & Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. New England Journal of Medicine 2005 353 249-254. (doi:10.1056/NEJMoa043690)
15. Hofsø D, Nordstrand N, Johnson LK, Karlsen TI, Hager H, Jenssen T, Bollerslev J, Godang K, Sandbu R, Røislien J & Hjelmesæth J. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. European Journal of Endocrinology 2010 163 735-745. (doi:10.1530/EJE-10-0514)
16. Hofsø D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, Aukrust P, Røislien J & Hjelmesæth J. Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. European Journal of Endocrinology 2009 161 451-458. (doi:10.1530/EJE-09-0421)
17. Alberti KG & Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998 15 539-553. (doi:10.1002/(SICI)1096-9136(199807)15:7!539::AID-DIA668O3.0. CO;2-S)
18. Matthews DR, Hosker JP & Rudenski AS. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883)
19. Belfiore F, Iannello S & Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Molecular Genetics and Metabolism 1998 63 134-141. (doi:10.1006/mgme.1997.2658)
20. Stumvoll M, Van HT, Fritsche A & Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001 24 796-797. (doi:10.2337/diacare.24.4.796)
21. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC & Palmer JP. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993 42 1663-1672. (doi:10.2337/diabetes.42.11.1663)
22. Larsson H & Ahren B. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. Journal of Clinical Endocrinology and Metabolism 1999 84 2068-2074. (doi:10.1210/jc.84.6.2068) (Pubitemid 30647035)
23. Fritsche A, Madaus A, Stefan N, Tschritter O, Maerker E, Teigeler A, Haring H & Stumvoll M. Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans. Diabetes 2002 51 S234-S239. (doi:10.2337/diabetes.51.2007.S234)
24. Weyer C, Hanson K, Bogardus C & Pratley RE. Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight. Diabetologia 2000 43 36-46. (doi:10.1007/ s001250050005)
25. Laferrere B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, Yapp K & Olivan B. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2008 93 2479-2485. (doi:10.1210/jc.2007-2851)
26. Swarbrick MM, Stanhope KL, Austrheim-Smith IT, Van L, Ali MR, Wolfe BM & Havel PJ. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008 51 1901-1911. (doi:10.1007/s00125-008-1118-5)